These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29201)

  • 1. Effect of chronic treatment with neuroleptics on the content of 3',5'-cyclic guanosine monophosphate in cerebellar cortex of rats.
    Biggio G; Corda MG; Casu M; Gessa GL
    Life Sci; 1978 Aug; 23(6):649-52. PubMed ID: 29201
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP).
    Breese GR; Mailman RB; Ondrusek MG; Harden TK; Mueller RA
    Life Sci; 1978 Aug; 23(5):533-6. PubMed ID: 29192
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
    Biggio G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
    Burkard WP; Pieri L; Haefely W
    Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo changes of guanosine 3',5'-cyclic phosphate in rat cerebellum by dopaminergic mechanisms.
    Burkard WP; Pieri L; Haefely W
    J Neurochem; 1976 Jul; 27(1):297-8. PubMed ID: 182922
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content.
    Mailman RB; Mueller RA; Breese GR
    Life Sci; 1978 Aug; 23(6):623-7. PubMed ID: 211362
    [No Abstract]   [Full Text] [Related]  

  • 8. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
    Biggio G; Costa E; Guidotti A
    Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
    [No Abstract]   [Full Text] [Related]  

  • 9. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

  • 10. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists.
    Biggio G; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine reduces cerebellar guanosine-3',5'-cyclic monophosphate content and elevates cerebrospinal fluid guanosine-3',5'-cyclic monophosphate content in rhesus monkey.
    Katz JB; Catravas GN; Valases C; Wright SJ
    Life Sci; 1978 Feb; 22(6):467-72. PubMed ID: 203814
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethanol-induced depletion of cerebellar guanosine 3',5' -cyclic monophosphate.
    Redos JD; Catravas GN; Hunt WA
    Science; 1976 Jul; 193(4247):58-9. PubMed ID: 180596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK modulation of cerebellar afferents: dopaminergic involvement.
    Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
    Puri SK; Choma P; Volicer L
    Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain nucleotides in naive and handling-habituated rats: differences in levels and drug-sensitivity.
    Corda MG; Biggio G; Gessa GL
    Brain Res; 1980 Apr; 188(1):287-90. PubMed ID: 6245755
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
    Biggio G; Guidotti A
    Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
    [No Abstract]   [Full Text] [Related]  

  • 17. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
    Mailman RB; Frye GD; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses.
    Lundberg DB; Breese GR; Mailman RB; Frye GD; Mueller RA
    Mol Pharmacol; 1979 Mar; 15(2):246-56. PubMed ID: 38389
    [No Abstract]   [Full Text] [Related]  

  • 19. Action in vitro and in vivo of chlorpromazine and haloperidol on cyclic nucleotide systems in mouse cerebral cortex and cerebellum.
    Palmer GC; Jones DJ; Medina MA; Palmer SJ; Stavinoha WB
    Neuropharmacology; 1978 Jul; 17(7):491-8. PubMed ID: 211456
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ethanol, arecoline, atropine and nicotine, alone and in various combinations, on rat cerebellar cyclic guanosine 3',5-monophosphate.
    Dodson RA; Johnson WE
    Neuropharmacology; 1979 Nov; 18(11):871-6. PubMed ID: 233143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.